Institutional Review Board

Entity type image
Type: Keyphrase
Name: Institutional Review Board
First reported May 22 2013 - Updated May 22 2013 - 2 reports

Echo Therapeutics receives IRB approval for its clinical trial of the Symphony CGM System

Echo Therapeutics Inc (Nasdaq:ECTE), a developer of a non-invasive, wireless, transdermal continuous glucose monitoring system, announced on Tuesday that the clinical trial of its Symphony CGM System has received Institutional Review Board (IRB) approval. ... [Published Individual.com - May 22 2013]
First reported May 21 2013 - Updated May 21 2013 - 5 reports

Echo Therapeutics Inc Announces Institutional Review Board (IRB) Approval For Clinical Trial Of Symphony CGM System

Echo Therapeutics Inc announced that the Company's clinical trial of Symphony CGM System has received Institutional Review Board (IRB) approval. The IRB approval enables the commencement of a clinical evaluation of Symphony that will support the Company's ... [Published Reuters - May 21 2013]
First reported May 16 2013 - Updated May 16 2013 - 1 reports

La Jolla Pharmaceutical completes Phase I chronic kidney disease trial

La Jolla Pharmaceutical Company, a developer of therapeutics targeting galectin proteins, has announced the completion of Phase I trial with the treatment of the last patient in the Phase I, or Part A, portion of the Phase I/II clinical trial of GCS-100 ... [Published Individual.com - May 16 2013]
First reported May 16 2013 - Updated May 16 2013 - 1 reports

Institutional Review Board Open House May 29

Learn about the structure and function of the UC IRB, and an overview of member responsibilities during two sessions, 8 a.m. and 4 p.m., Wednesday May 29, in University Hall. Ample time will be provided for questions, and refreshments will be served. ... [Published University of Cincinnati - May 16 2013]
First reported May 16 2013 - Updated May 16 2013 - 1 reports

CONBA Affiliate Wins License for Cancer Clinical Tests

Zhejiang CONBA Pharmaceutical Co., Ltd. (SHSE: 600572) revealed that wholly owned subsidiary Hong Kong Conba International has received a notice from Superlab Far East Limited in which it has a stake, saying that the latter got licenses for phase I clinical ... [Published Individual.com - May 16 2013]
First reported May 14 2013 - Updated May 14 2013 - 1 reports

DBT Announces Phase III Clinical Trial Results of Rotavirus Vaccine Developed in India Say Vaccine Demonstrates Strong Efficacy

This is an important scientific breakthrough against rotavirus infections, the most severe and lethal cause of childhood diarrhoea, responsible for approximately 100,000 deaths of small children in India each year, said DBT Secretary Dr K. VijayRaghavan. ... [Published Web Newswire - May 14 2013]
First reported May 08 2013 - Updated May 09 2013 - 1 reports

Auburn University at Montgomery professor set to retire after 40 years at the university

MONTGOMERY, Alabama -- Auburn University at Montgomery associate professor of political science and public administration Brad Moody is retiring after arriving at AUM in 1972.During his 40 years at the university, he estimates that he has taught more ... [Published al.com - May 08 2013]
First reported May 08 2013 - Updated May 08 2013 - 2 reports

Brewer makes way for marijuana research on Arizona university campuses

Gov. Jan Brewer has cleared one hurdle for new research on the possible medical benefits of marijuana. Without comment the governor on Tuesday signed legislation to permit possession of the drug on college and university campuses. The measure takes effect ... [Published East Valley Tribune - May 08 2013]
First reported May 04 2013 - Updated May 04 2013 - 1 reports

Research Process: Science vs. Marketing: Which Comes First?

Well-designed clinical trials on ingredients and finished products should create the foundation for marketing to consumers.Related Searches: • Nutritional • Regulatory • Dietary Supplements •Related ColumnsIs anyone really surprised anymore when they ... [Published Nutraceuticals World - May 04 2013]
First reported May 01 2013 - Updated May 01 2013 - 1 reports

Hangover Research Institute Submits Study to Institutional Review Board

The first research institute of its kind, the Hangover Research Institute (HRI) will make history by submitting a formal hangover research study to an Institutional Review Board (IRB) located in Las Vegas, NV. The study focuses on the work first initiated ... [Published Zecco - May 01 2013]
First reported Apr 30 2013 - Updated Apr 30 2013 - 1 reports

The road to enrollment in Phase 1 clinical trials is a long one: Clues to Cancer

It all depends on the complexity of a trial; how new the drug is; how original the question is; and whether the trial is created by a physician or scientist at a hospital or cancer center, a pharmaceutical company or a cooperative oncology group.The Cleveland ... [Published The Plain Dealer - Apr 30 2013]
First reported Apr 24 2013 - Updated Apr 24 2013 - 1 reports

SURVEY: Please share your thoughts on online accounting degrees.

Our friends at the Kentucky Society of CPAs have asked for your thoughts! We will be sharing the results at the survey's conclusion on May 10.The accounting faculty of Murray State University is interested in an answer to the question: How willing are ... [Published Connecticut Society Certified Public Accountants - Apr 24 2013]

Quotes

...them to provide cutting-edge solutions that dramatically impact the cost and efficiency of clinical trials," said Anthony Costello, CEO of Mytrus. "We are pleased that The WIRB-Copernicus Group has recognized the innovation of our technology and has chosen to offer our e-consent application in its comprehensive suite of research oversight solutions."
...This IRB approval signals a long-awaited CE Mark regulatory trial initiation," commented Dr. Mooney. "Our team's hard work and extreme dedication have put us in a very strong position to begin the process of securing Symphony's market approval by European regulatory agencies."
...of childhood diarrhoea, responsible for approximately 100,000 deaths of small children in India each year," said DBT Secretary Dr K VijayRaghavan. "The clinical results indicate that the vaccine, if licensed, could save the lives of thousands of children each year in India."
"Though the differences are not statistically significant, they may reflect meaningful differences in the prescription rate and effectiveness of lipid-lowering interventions, including statins and lifestyles, between genders" wrote investigators in the study...

More Content

All (120) | News (101) | Reports (1) | Blogs (10) | Audio/Video (0) | Fact Sheets (0) | Press Releases (8)
sort by: Date | Relevance
Mayo Foundation for Medical Education and Resea... [Published TransWorldNews - 22 hours ago]
SENIOR NEWS, MAY 23: Sign up on June 12 for Ply... [Published Foxboro Reporter - May 23 2013]
The WIRB-Copernicus Group Joins Forces with Myt... [Published Zecco - May 23 2013]
FDA approves first study on ecstasy-assisted th... [Published Raw Story - May 22 2013]
COHELLP: collaborative randomized controlled tr... [Published 7thSpace - May 22 2013]
Echo Therapeutics receives IRB approval for its... [Published Individual.com - May 22 2013]
Echo Therapeutics Inc wins IRB's approval to co... [Published Individual.com - May 22 2013]
Clinical trial regulation in Mexico [Published PMLive - May 22 2013]
Echo Therapeutics Inc Announces Institutional R... [Published Reuters - May 21 2013]
Clinical trial of Echo Therapeutics' Symphony C... [Published News-Medical.Net - May 21 2013]
Echo Therapeutics Announces IRB Approval for Tr... [Published Equities.com - May 21 2013]
Echo Therapeutics (ECTE) Gets IRB Approval for ... [Published Street Insider - May 21 2013]
Echo Therapeutics Announces IRB Approval for Tr... [Published Benzinga.com - May 21 2013]
The WIRB-Copernicus Group Partners with Mytrus,... [Published TickerTech.com - May 20 2013]
Rotavirus Vaccine Developed in India Demonstrat... [Published IndiaPRwire - May 19 2013]
Decades of Improving Cholesterol Levels Abruptl... [Published Advance for Administrators of the Laboratory - May 19 2013]
Neuralstem (NYSE MKT: CUR) Q1/13 Results – SELL... [Published Proactive Investors USA - May 17 2013]
La Jolla Pharmaceutical completes Phase I chron... [Published Individual.com - May 16 2013]
New Survey Results from 3,000 Postmenopausal Wo... [Published KCTV 5 - May 16 2013]
Institutional Review Board Open House May 29 [Published University of Cincinnati - May 16 2013]
CONBA Affiliate Wins License for Cancer Clinica... [Published Individual.com - May 16 2013]
Rice University Has Help for People with Epilepsy [Published HealthNewsDigest.com - May 16 2013]
People [Published Arlington Connection - May 15 2013]
DBT Announces Phase III Clinical Trial Results ... [Published Web Newswire - May 14 2013]
DBT Announces Phase III Clinical Trial Results ... [Published Press Information Bureau - May 14 2013]
Rotavirus vaccine developed in India demonstrat... [Published EurekAlert! - May 14 2013]
Decades of Improving Cholesterol Levels Abruptl... [Published TickerTech.com - May 13 2013]
Rice has help for people with epilepsy [Published Rice University - May 13 2013]
Pairwise agonist scanning-flow cytometry (PAS-F... [Published Bio Techniques - May 10 2013]
Neuralstem Reports First Quarter Financial Resu... [Published Zecco - May 10 2013]
1 2 3 4
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
FDA approves first study on ecstasy-assisted th... [Published Raw Story - May 22 2013]
Topics: Brad Burge ♦ social anxietyLike Raw Story on FacebookThe U.S. Federal Drug Administration in late April approved a study to examine whether the drug ecstasy could help autistic adults suffering from social anxiety. But the first-of-its-kind study ...
4 Healthcare Stock Stories for Thursday Investm... [Published Wall St. Cheat Sheet - Apr 18 2013]
Acura Pharmaceuticals ( NASDAQ:ACUR ): Current price $2.64 The FDA has approved updated labeling for Purdue Pharma’s reformulated OxyContin (oxycodone hydrochloride controlled-release) tablets. The new labeling indicates that the product has physical ...
Stanislaw Burzynski versus regulations protecti... [Published ScienceBlogs : Combined Feed - Mar 26 2013]
Here we go again. Every time I think I can get away from this topic for a while, I get sucked back in. Indeed, it seems that hardly a week can go by when I don’t find myself pulled inexorably back to this horrible, horrible clinic and what I consider ...
A Doctor Can Finally Tell Fresenius: ‘I Told Yo... [Published Pharmalot - Feb 20 2013]
Last year, we wrote that Fresenius Kabi got into a tussle with a Danish professor after he and several colleagues published a paper in The New England Journal of Medicine that concluded its hydroxyethyl starch treatment for sepsis may cause kidney failure ...
Would You Let a Coin Toss Decide Your Future? F... [Published Freakonomics - Jan 31 2013]
This is a transcript of the Freakonomics Radio podcast “ Would You Let a Coin Toss Decide Your Future? ” [MUSIC: Ed Hartman ; “Happy Marimba”] Stephen J. DUBNER : If you ask Daniel Herrington to introduce himself, tell you what he does, this ...
1 2

Press Releases

sort by: Date | Relevance
Vivify Health Receives Funding to Accelerate Av... [Published Business Wire - May 01 2013]
Dignitana AB ( publ) uppdatering USA [Published GlobeNewswire: Acquisitions News - Mar 25 2013]
Mathematica Policy Research Partners with New E... [Published EON Health & Medicine - Feb 20 2013]
Mathematica Policy Research Partners with New E... [Published Business Wire Science: Science News - Feb 20 2013]
Mathematica Policy Research Partners with New E... [Published Business Wire Professional Services News - Feb 20 2013]
1 2
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2013 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.